View in EDS HTML Full Text PDF Full Text

Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study.

Saved in:
Bibliographic Details
Title: Zanubrutinib for treatment‐naïve and relapsed/refractory chronic lymphocytic leukaemia: long‐term follow‐up of the phase I/II AU‐003 study.
Authors: Cull, Gavin1,2 (AUTHOR), Burger, Jan A.3 (AUTHOR), Opat, Stephen4,5 (AUTHOR), Gottlieb, David6 (AUTHOR), Verner, Emma7,8 (AUTHOR), Trotman, Judith7,8 (AUTHOR), Marlton, Paula9,10 (AUTHOR), Munoz, Javier11 (AUTHOR), Johnston, Patrick12 (AUTHOR), Simpson, David13,14 (AUTHOR), Stern, Jennifer C.14 (AUTHOR), Prathikanti, Radha14 (AUTHOR), Wu, Kenneth14,15 (AUTHOR), Novotny, William14 (AUTHOR), Huang, Jane14,15 (AUTHOR), Tam, Constantine S.16,17,18,19 (AUTHOR) constantine.tam@petermac.org
Source: British Journal of Haematology. Mar2022, Vol. 196 Issue 5, p1209-1218. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00071048
DOI:10.1111/bjh.17994